University of Maryland Medical Center Fayette Clinic

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient

Facility Type

Community mental health center

Pharmacotherapies

Fluphenazine Haloperidol Loxapine Aripiprazole Cariprazine Clozapine Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

Medicare Medicaid Private health insurance

Special Programs/Groups Offered

Seniors or older adults Criminal justice (other than DUI/DWI)/Forensic clients Clients with co-occurring mental and substance use disorders Clients who have experienced trauma Persons with post-traumatic stress disorder (PTSD) Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking permitted in designated area

Age Groups Accepted

Young Adults Seniors

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Court-ordered outpatient treatment Family psychoeducation Illness management and recovery Case management service Integrated primary care services